Back to Search
Start Over
Natural D240G Toho-1 mutant conferring resistance to ceftazidime: biochemical characterization of CTX-M-43.
- Source :
-
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2008 Nov; Vol. 62 (5), pp. 991-7. Date of Electronic Publication: 2008 Aug 27. - Publication Year :
- 2008
-
Abstract
- Objectives: The aim of this article is biochemical and kinetic characterization of CTX-M-43, a natural Asp-240-->Gly mutant of CTX-M-44 (ex Toho-1), from a clinical isolate of Acinetobacter baumannii isolated in a Bolivian hospital.<br />Methods: Steady-state kinetic parameters (K(m) and k(cat)) were determined for a large pattern of substrates. Analysis of inactivators and transient inactivators was performed to determine the efficiency of acylation (k(+2)/K) and the deacylation constant (k(+3)). Molecular modelling of Michaelis complex of ceftazidime, cefotaxime and ceftibuten, obtained from molecular mechanics calculations, was carried out.<br />Results: CTX-M-43 showed a general increase in affinity towards all cephalosporins tested, with respect to CTX-M-44. Carbapenems acted as inactivators with a good acylation efficiency for meropenem and ertapenem and significant deacylation constant for imipenem. MICs of imipenem obtained at a higher bacterial inoculum of recombinant Escherichia coli were increased.<br />Conclusions: Kinetic data and molecular modelling of Michaelis complex confirmed that Asp-240-->Gly allows a better accommodation of the bulky C7beta aminothiazol-oxyimino substituent, resulting in a general increase in the enzyme affinity towards oxyimino cephalosporins. The ascertained potentialities of CTX-M-type enzymes, supported by the kinetic data and the behaviour of the recombinant E. coli at different bacterial inocula towards carbapenems, make a possible evolution of those enzymes towards a carbapenemase activity plausible.
- Subjects :
- Acinetobacter Infections microbiology
Acinetobacter baumannii genetics
Acinetobacter baumannii isolation & purification
Adult
Amino Acid Substitution genetics
Bolivia
Escherichia coli drug effects
Escherichia coli genetics
Humans
Kinetics
Microbial Sensitivity Tests
Models, Molecular
Protein Structure, Tertiary
Substrate Specificity
beta-Lactamases genetics
Acinetobacter baumannii enzymology
Anti-Bacterial Agents pharmacology
Ceftazidime pharmacology
Mutation, Missense
beta-Lactamases metabolism
beta-Lactams metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 1460-2091
- Volume :
- 62
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- The Journal of antimicrobial chemotherapy
- Publication Type :
- Academic Journal
- Accession number :
- 18755695
- Full Text :
- https://doi.org/10.1093/jac/dkn339